+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-04-26Number of Pages: 236

Peptide Therapeutics Market (Application - Cancer, Metabolic, CVD, Respiratory, GIT, Anti-infective, Dermatology, CNS, and Renal; Route of Administration – Parenteral and Oral; Type - Innovative and Generic; Technology - Liquid Phase, Solid Phase, and Hybrid Phase; Type of Molecule - Vasopressin, Somatostatin, Calcitonin, and Natriuretic, Immunopeptide; API Peptide Type - In-house and CMO) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

1. Preface
     1.1. Research Scope
     1.2. Market Segmentation
     1.3. Research Objectives
     1.4. Key Questions Answered

2. Assumptions and Research Methodology
     2.1. Report Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary
     3.1. Global Peptide Therapeutics Market Snapshot
     3.2. Market Opportunity Map

4. Market Overview
     4.1. Product Overview
     4.2. Death Rate of Leukemia, by Country
     4.3. Death Rate of Cancer, by Country

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunities
     5.5. Opportunity Analysis
     5.6. White Space Analysis
     5.7. Porter’s Analysis
     5.8. Pipeline Analysis (Phase III)
     5.9. Peptide Drug Chemical Structure Trend Analysis
     5.10. Separation Media for Peptide Drug Manufacturing

6. Global Peptide Therapeutics Market Analysis, by Application
     6.1. Key Findings
     6.2. Introduction
     6.3. Cancer
     6.4. Metabolic
     6.5. CVD
     6.6. Respiratory
     6.7. GIT
     6.8. Anti-infective
     6.9. Dermatology
     6.10. CNS
     6.11. Renal
     6.12. Others
     6.13. Key Trends
     6.14. Market Attractiveness Analysis

7. Global Peptide Therapeutics Market Analysis, by Route of Administration
     7.1. Key Findings
     7.2. Introduction
     7.3. Parenteral
     7.4. Oral
     7.5. Others
     7.6. Key Trends
     7.7. Market Attractiveness Analysis

8. Global Peptide Therapeutics Market Analysis, by Type
     8.1. Key Findings
     8.2. Introduction
     8.3. Innovative
     8.4. Generic
     8.5. Key Trends
     8.6. Market Attractiveness Analysis

9. Global Peptide Therapeutics Market Analysis, by Technology
     9.1. Key Findings
     9.2. Introduction
     9.3. Liquid Phase
     9.4. Solid Phase     
     9.5. Hybrid Phase
     9.6. Market Attractiveness Analysis

10. Global Peptide Therapeutics Market Analysis, by Type of Molecule
     10.1. Key Findings
     10.2. Introduction
     10.3. Vasopressin
     10.4. Somatostatin
     10.5. Calcitonin
     10.6. Immunopeptide
     10.7. Natriuretic
     10.8. Others
     10.9. Market Attractiveness Analysis

11. Global API Peptide Therapeutics Market Analysis, by Type
     11.1. Key Findings
     11.2. Introduction
     11.3. In-house
     11.4. CMO
     11.5. Market Attractiveness Analysis

12. Global Peptide Therapeutics Market Analysis, by Region
     12.1. Regulatory Framework
     12.2. North America
     12.3. Europe
     12.4. Asia Pacific
     12.5. Latin America
     12.6. Middle East & Africa
     12.7. Market Attractiveness Analysis

13. North America Peptide Therapeutics Market Analysis
     13.1. North America Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
     13.2. North America Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
     13.3. North America Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
     13.4. North America Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
     13.5. North America Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
     13.6. North America Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

14. Europe Peptide Therapeutics Market Analysis
     14.1. Europe Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
     14.2. Europe Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
     14.3. Europe Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
     14.4. Europe Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
     14.5. Europe Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
     14.6. Europe Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

15. Asia Pacific Peptide Therapeutics Market Analysis
     15.1. Asia Pacific Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
     15.2. Asia Pacific Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
     15.3. Asia Pacific Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
     15.4. Asia Pacific Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
     15.5. Asia Pacific Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
     15.6. Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

16. Latin America Peptide Therapeutics Market Analysis
     16.1. Latin America Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
     16.2. Latin America Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
     16.3. Latin America Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
     16.4. Latin America Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
     16.5. Latin America Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
     16.6. Latin America Peptide Therapeutics Market Attractiveness Analysis, 2016-2024
     16.7. Latin America Peptide Therapeutics Market Attractiveness Analysis

17. Middle East & Africa Peptide Therapeutics Market Analysis
     17.1. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Country, 2016-2024
     17.2. Middle East & Africa Peptide Therapeutics Therapy Market Size Forecast, By Application, 2016-2024
     17.3. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Route of Administration, 2016-2024
     17.4. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Type, 2016-2024
     17.5. Middle East & Africa Peptide Therapeutics Market Size Forecast, By Technology, 2016-2024
     17.6. Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, 2016-2024

18. Competitive Landscape
     18.1. Market Share Analysis by Company (2015)
     18.2. Competition Matrix
             18.2.1. Teva Pharmaceutical Industries Ltd.
             18.2.2. GlaxoSmithKline
             18.2.3. Novartis AG 
             18.2.4. Pfizer, Inc. 
             18.2.5. F. Hoffmann-La Roche Ltd. 
             18.2.6. Bachem Holding AG
             18.2.7. Sanofi

19. Company Profiles
     19.1. Amgen, Inc.
             19.1.1. Company Details
             19.1.2. Company Description
             19.1.3. Business Overview
             19.1.4. SWOT Analysis
             19.1.5. Financial Analysis
             19.1.6. Strategic Overview
     19.2. Bachem Holding AG
             19.2.1. Company Details
             19.2.2. Company Description
             19.2.3. Business Overview
             19.2.4. SWOT Analysis
             19.2.5. Financial Analysis
             19.2.6. Strategic Overview
     19.3. Eli Lilly and Company
             19.3.1. Company Details
             19.3.2. Company Description
             19.3.3. Business Overview
             19.3.4. SWOT Analysis
             19.3.5. Financial Analysis
             19.3.6. Strategic Overview
     19.4. F. Hoffmann-La Roche Ltd.
             19.4.1. Company Details
             19.4.2. Company Description
             19.4.3. Business Overview
             19.4.4. SWOT Analysis
             19.4.5. Financial Analysis
             19.4.6. Strategic Overview
     19.5. GlaxoSmithKline Plc
             19.5.1. Company Details
             19.5.2. Company Description
             19.5.3. Business Overview
             19.5.4. SWOT Analysis
             19.5.5. Financial Analysis
             19.5.6. Strategic Overview
     19.6. Novartis AG
             19.6.1. Company Details
             19.6.2. Company Description
             19.6.3. Business Overview
             19.6.4. SWOT Analysis
             19.6.5. Financial Analysis
             19.6.6. Strategic Overview
     19.7. Pfizer, Inc.
             19.7.1. Company Details
             19.7.2. Company Description
             19.7.3. Business Overview
             19.7.4. SWOT Analysis
             19.7.5. Financial Analysis
             19.7.6. Strategic Overview
     19.8. Sanofi
             19.8.1. Company Details
             19.8.2. Company Description
             19.8.3. Business Overview
             19.8.4. SWOT Analysis
             19.8.5. Financial Analysis
             19.8.6. Strategic Overview
     19.9. Takeda Pharmaceutical Company Limited
             19.9.1. Company Details
             19.9.2. Company Description
             19.9.3. Business Overview
             19.9.4. SWOT Analysis
             19.9.5. Financial Analysis
             19.9.6. Strategic Overview
     19.10. Teva Pharmaceutical Industries Ltd.
             19.10.1. Company Details
             19.10.2. Company Description
             19.10.3. Business Overview
             19.10.4. SWOT Analysis
             19.10.5. Financial Analysis
             19.10.6. Strategic Overview

List of Figures

FIG. 1 Global Peptide Therapeutics Market Value Share Analysis, by Application, 2015 and 2024
FIG. 2 Global Cancer Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 3 Global Metabolic Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 4 Global CVD Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 5 Global Respiratory Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 6 Global GIT Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 7 Global Anti-infective Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 8 Global Dermatology Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 9 Global CNS Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 10 Global Renal Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 11 Global Others Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 12 Peptide Therapeutics Market Attractiveness Analysis, by Application
FIG. 13 Global Peptide Therapeutics Market Value Share Analysis, by Route of Administration, 2015 and  2024
FIG. 14 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Parenteral, 2016–2024
FIG. 15 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Oral, 2016–2024
FIG. 16 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Others, 2016–2024
FIG. 17 Global Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 18 Peptide Therapeutics Market Value Share Analysis, by Type, 2015 and 2024
FIG. 19 Innovative Peptide Therapeutics Market Size (US$ Mn), 2016–2024
FIG. 20 Generic Peptide Therapeutics Market Size (US$ Mn), 2016–2024
FIG. 21 Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 22 Global Peptide Therapeutics Market Value Share Analysis, by Technology, 2015 and 2024
FIG. 23 Global Liquid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 24 Global Solid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 25 Global Hybrid Phase Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 26 Global Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 27 Global Peptide Therapeutics Market Value Share Analysis, by Type of Molecules, 2015 and 2024
FIG. 28 Global Vasopressin Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 29 Global Somatostatins Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 30 Global Calcitonin Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 31 Global Immunopeptides Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 32 Global Natriuretic Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 33 Global Other Peptides Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 34 Peptide Therapeutics Market Attractiveness Analysis, by Type of Molecule
FIG. 35 API Peptide Therapeutics Market Value Share Analysis, by Type, 2015 and 2024
FIG. 36 In-house Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 37 CMO Peptide Therapeutics Market Size Forecast (US$ Mn), 2016–2024
FIG. 38 API Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 39 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 40 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 41 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 42 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 43 MEA Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 44 Global Peptide Therapeutics Market Attractiveness Analysis, by Region
FIG. 45 U.S. Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 46 Canada Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 47 North America Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 48 North America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 49 North America Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 50 North America Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 51 Germany Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 52 U.K. Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 53 France Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 54 Italy Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 55 Spain Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 56 Rest of Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 57 Europe Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 58 Europe Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 59 Europe Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 60 Europe Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 61 Japan Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 62 China Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 63 India Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 64 Rest of APAC Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 65 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 66 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 67 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 68 Asia Pacific Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 69 Brazil Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 70 Mexico Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 71 Rest of LATAM Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 72 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 73 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 74 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 75 Latin America Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 76 South Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 77 Saudi Arabia Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 78 Rest of MEA Peptide Therapeutics Market Size (US$ Mn) Forecast, 2016–2024
FIG. 79 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Country
FIG. 80 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Route of Administration
FIG. 81 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Type
FIG. 82 Middle East & Africa Peptide Therapeutics Market Attractiveness Analysis, by Technology
FIG. 83 Peptide Therapeutics Market Share Analysis By Company (2015)

List of Tables

TABLE 1 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 2 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Route of Administration, 2016–2024
TABLE 3 Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 4 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 5 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 6 API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 7 Global Peptide Therapeutics Market Size (US$ Mn) Forecast, by Region, 2016–2024
TABLE 8 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 9 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 10 North America Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 11 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 12 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 13 North America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 14 North America API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 15 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 16 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 17 Europe Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 18 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 19 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 20 Europe Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 21 Europe API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 22 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 23 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 24 Asia Pacific Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 25 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 26 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 27 Asia Pacific Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 28 Asia Pacific API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 29 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 30 Latin America  Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 31 Latin America Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 32 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 33 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 34 Latin America Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 35 Latin America API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 36 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Country, 2016–2024
TABLE 37 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Application, 2016–2024
TABLE 38 Middle East & Africa Peptide Therapeutics Market Size (US$) Forecast, by Route of Administration, 2016–2024
TABLE 39 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024
TABLE 40 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Technology, 2016–2024
TABLE 41 Middle East & Africa Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type of Molecule, 2016–2024
TABLE 42 Middle East & Africa API Peptide Therapeutics Market Size (US$ Mn) Forecast, by Type, 2016–2024


 
 
Back To Top